Blood News and Research

RSS

Biogen Idec initiates enrollment in Phase II BG-12 combination trial for relapsing-remitting multiple sclerosis

Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).

15 Jun 2010

Epocal receives FDA marketing clearance for new lactate test on epoc Blood Analysis System

Epocal, Inc., a leading edge provider of point of care technology, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market its new lactate test on the epoc Blood Analysis System. Lactate measurements from the epoc System are used to evaluate acid-base status and for diagnosis and treatment of lactic acidosis (abnormally high acidity of the blood).

15 Jun 2010

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Researchers reported today that Soliris® (eculizumab), a first-in-class terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc., may provide clinical benefits to patients with thrombotic microangiopathy (TMA) resulting from uncontrolled complement activation. TMA, the formation of blood clots in capillaries and small arteries, can lead to life-threatening damage in multiple organs including kidney failure, thrombocytopenia (abnormally low platelet count) and anemia.

15 Jun 2010

Central Washington Hospital improves patient experience with Toshiba' Vantage Titan MR system

In today's demanding health care environment, many community hospitals require imaging equipment that provides a variety of advanced diagnostic exams with features that improve patient cooperation. To offer a variety of high-quality, comfortable MR exams to its patients, Central Washington Hospital in Wenatchee, Wash., selected Toshiba America Medical Systems' Vantage TitanTM MR system.

15 Jun 2010

Pieris commences PRS-050 anti-VEGF Anticalin Phase I clinical trial for cancer

Pieris AG announced today the initiation of a Phase I clinical trial in cancer patients for its lead program, PRS-050, an anti-VEGF Anticalin. The trial is an open-label, dose-escalating evaluation of the compound's safety and tolerability in patients with solid tumors. Conducted at three sites in Germany, the trial is underway and patients from the first cohort have been dosed.

15 Jun 2010

New studies: Politicians could do more to tackle the spread of obesity

Politicians could do more to tackle the spread of obesity, a new series of studies suggests. Governments are being urged to encourage better eating habits by supporting financial incentives to enable production of healthier foods, such as subsidised fruit and vegetable production and levies on calorie-rich foods.

15 Jun 2010

New insight into sleeping sickness parasite

Fresh discoveries about the parasite that causes sleeping sickness could lead to new avenues of research into treatments for the disease.

15 Jun 2010

SIRS-Lab, Analytik Jena partner in molecular sepsis diagnostics

SIRS-Lab GmbH and Analytik Jena AG, also based in Jena, will be strengthened by working together in the field of molecular sepsis diagnostics. As part of this cooperation, Analytik Jena subsidiary AJ Innuscreen GmbH will provide the partner with a platform for automated isolation of nucleic acids with the associated reagent system worth almost half a million euro.

15 Jun 2010

Cardio-perfusion circuit patent portfolio offered for sale

ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L), is offering for sale a portfolio of three US issued patents relating to a condensed perfusion circuit for cardiac bypass. The technology of the portfolio should be of interest to any medical device company currently working in the cardiac surgery sector, or looking to establish a leading position in this growing field. This portfolio is a strong addition to ICAP Ocean Tomo's growing Bio/Life Sciences practice.

15 Jun 2010

Early administration of tranexamic acid to patients with severe bleeding injuries saves lives

If recently injured patients with serious bleeding were to receive a cheap, widely available and easily administered drug to help their blood to clot, tens of thousands of lives could be saved every year, according to a paper published on-line today by The Lancet.

15 Jun 2010

CT angiography not necessary in patients suspected with pulmonary embolism

A new study suggests that computed tomography (CT) angiography might be unnecessary in many patients suspected of having pulmonary embolism (PE), based on the results of risk assessment analysis. PE risk assessment could help reduce radiation exposure and costs associated with CT angiography. The results of the study appear in the online edition and August print issue of the journal Radiology.

15 Jun 2010

Researchers discover microRNA biomarkers to treat patients with SCLC

Researchers at the Translational Genomics Research Institute, the Van Andel Research Institute and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have discovered a biomarker that could help in the treatment of patients with an aggressive type of lung cancer.

15 Jun 2010

Study shows NAT programs increase HIV detection yield by 23%

Community-based HIV testing programs generally use only HIV antibody testing, but nucleic acid testing can detect the presence of HIV earlier. Researchers at the University of California, San Diego School of Medicine studied more than 3,000 patients who sought HIV testing in community-based clinics in or near San Diego to examine the yield of testing with a rapid test plus NAT and to see whether patients would be willing to access their results by phone or computer.

15 Jun 2010

2,300 researchers under one roof at American Society of Echocardiography 21st Annual Scientific Sessions

Research released today at the American Society of Echocardiography (ASE) 21st Annual Scientific Sessions unveiled findings that will have a significant impact on the diagnosis and treatment of heart disease and the application of echocardiography in the future.

15 Jun 2010

Noninvasive carotid artery ultrasound helps avoid coronary angiography

New research from NYU Langone Medical Center shows that a simple, inexpensive and noninvasive carotid artery ultrasound of the neck can be used as a preliminary diagnostic tool for coronary artery disease (CAD). This may be an alternative to the standard, expensive and more invasive coronary angiography.

15 Jun 2010

New research shows astrocytes play important role in the function of nerve cells

Astrocytes are the most common type of cell in the brain and play an important role in the function of neurons - nerve cells. New research from the University of Gothenburg, Sweden, shows that they are also directly involved in the regulation of signalling between neurons.

15 Jun 2010

Entomologists to develop genetically engineered bacteria for killing mosquito larvae

Roughly half the world's population still lives in areas at risk of malaria transmission. Even in the United States, 1500 cases of malaria are reported annually on average.

15 Jun 2010

WHO calls for more blood donations worldwide

Seventy-seven countries do not have a blood donation rate high enough to meet "the basic needs for blood transfusions," the Associated Press reports. The WHO released new global data on blood donation for World Blood Donor Day on June 14. "[H]alf of the global blood donations are collected in developed nations, home to only 16 percent of the world's population," according to the AP (6/11).

15 Jun 2010

Researchers establish link between air pollution and SDB

Researchers from Brigham and Women's Hospital and the Harvard School of Public Health have established the first link between air pollution and sleep-disordered breathing, a known cause of cardiovascular diseases.

15 Jun 2010

CLC-5 protein plays active part in inherited kidney disorder: Scientists

Scientists from the University of Leeds have discovered the mechanisms of a protein known to play an active part in the inherited kidney disorder, Dent's disease. The findings provide a new focus for future therapies for the disease, for which there is currently no cure.

15 Jun 2010

Blood News and Research

Biogen Idec initiates enrollment in Phase II BG-12 combination trial for relapsing-remitting multiple sclerosis

Epocal receives FDA marketing clearance for new lactate test on epoc Blood Analysis System

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Central Washington Hospital improves patient experience with Toshiba' Vantage Titan MR system

Pieris commences PRS-050 anti-VEGF Anticalin Phase I clinical trial for cancer

New studies: Politicians could do more to tackle the spread of obesity

New insight into sleeping sickness parasite

SIRS-Lab, Analytik Jena partner in molecular sepsis diagnostics

Cardio-perfusion circuit patent portfolio offered for sale

Early administration of tranexamic acid to patients with severe bleeding injuries saves lives

CT angiography not necessary in patients suspected with pulmonary embolism

Researchers discover microRNA biomarkers to treat patients with SCLC

Study shows NAT programs increase HIV detection yield by 23%

2,300 researchers under one roof at American Society of Echocardiography 21st Annual Scientific Sessions

Noninvasive carotid artery ultrasound helps avoid coronary angiography

New research shows astrocytes play important role in the function of nerve cells

Entomologists to develop genetically engineered bacteria for killing mosquito larvae

WHO calls for more blood donations worldwide

Researchers establish link between air pollution and SDB

CLC-5 protein plays active part in inherited kidney disorder: Scientists

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News